1. Quality of life at one year was improved in patients with heart failure with preserved ejection fraction (HFpEF) who ...
1. For patients with a history of lymphoma or breast cancer, anthracycline use is associated with a higher incidence of ...
1. In this randomized clinical trial, among 2859 patients, death occurred in 26.1% of patients randomized to torsemide and 26.2% ...
1. A hospital-based strategy to support clinical decision-making and rapid follow-up resulted in a lower risk of death and hospitalization ...
1. Risk of hospital admission was lower in the ferric derisomaltose group versus usual care. 2. Treatment-related adverse events were ...
1. There was no association detected between PCSK9 gene variants and alterations in cardiac morphology. 2. The odds of having ...
1. In this secondary analysis of the PARADIGM-HF trial, the association between the New York Heart Association (NYHA) classification and ...
1. SGLT2 inhibitors reduced the risk of kidney disease progression by 37% overall, with comparable effects in patients with and ...
1. In this decision analytical model study among 4.8 million adults with heart failure in the United States, optimal implementation ...
